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Purpose: Retroperitoneal iliac procedures can enable successful endovascular repair of abdominal aortic aneurysm (AAA)
in patients who otherwise would not be anatomically eligible. The purpose of this study was to determine perioperative
outcome with adjunctive retroperitoneal procedures compared with standard bilateral femoral exposure.
Methods: Between August 1997 and November 2002, 164 patients underwent elective endovascular AAA repair at a single
university medical center. Anatomic, demographic, and early postoperative outcome data gathered prospectively were
analyzed. Thirty-two patients (20%) underwent 38 separate adjunctive retroperitoneal procedures. Indications included
small external iliac arteries (16 of 32 patients; 50%) and concomitant iliac aneurysm that precluded fixation of the
endograft limbs in the common iliac arteries (16 of 32 patients; 50%). The 38 procedures consisted of 8 iliac conduits
only, 14 iliac conduits with iliofemoral bypass grafts, and 16 hypogastric revascularization procedures. Data for the study
patients were compared with data for 132 patients who underwent endovascular AAA repair through femoral incisions.
Primary end points were hospital length of stay, and early morbidity and mortality.
Results: Retroperitoneal procedures enabled an additional 14% of patients with AAA to undergo endovascular techniques.
However, there was a significantly higher proportion of women and patients at high risk for anesthesia (American Society
of Anesthesiologists class IV or higher) in the group who underwent retroperitoneal procedures. On average, retroper-
itoneal procedures were associated with 2.6-fold greater blood loss, 82% longer procedure time, 1.5 days additional
hospital stay, and 1.8-fold higher rate of perioperative complications, compared with endovascular AAA repair with
femoral exposure alone. In contrast, early mortality was similar in the two groups.
Conclusion: Adjunctive retroperitoneal procedures during endovascular AAA repair are associated with increased risk for
complications and longer hospital length of stay, compared with AAA repair with standard femoral exposure only. They
do not, however, increase early mortality, even in patients at high risk, and enable a larger subset of patients with AAA
to undergo endovascular repair. (J Vasc Surg 2003;38:459-65.)
More than 13,000 endovascular abdominal aortic an-
eurysm (AAA) repair procedures are performed in the
United States each year. Three devices are currently com-
mercially available (Ancure; Guidant/EVT, Menlo Park,
Calif; AneuRx, Medtronic/AVE, Santa Rosa, Calif; and
Excluder, W. L. Gore & Associates, Flagstaff, Ariz) that
may be used for these procedures, and at least seven others
are under various stages of clinical investigation. Although
individual designs in construction and deployment differ in
several substantive ways, each device has been designed for
use in a similar subset of infrarenal aortoiliac anatomy,
including proximal aortic neck diameter 18 to 26 mm,
minimum neck length 15 mm, common iliac artery diam-
eter 8 to 15 mm with minimum contiguous length 20 mm,
and common femoral and external iliac artery diameter
greater than 7 mm, to enable safe passage of the delivery
catheters. Other anatomic considerations (eg, angulation,
tortuosity, thrombus) may collectively be important in
proper patient selection, but the physical dimensions of the
proximal and distal fixation sites are the most critical limit-
ing factors for success or failure of the procedure.
Previous studies have estimated that, with these crite-
ria, approximately 30% to 60% of patients with AAA are
anatomically suitable for endovascular repair.1,2 As sur-
geons have gained experience with these devices, unique
adjunctive surgical techniques have been developed to
manage complex iliac anatomy through limited pelvic ret-
roperitoneal exposure, which, while preserving the mini-
mally invasive benefits of these procedures, have expanded
the subset of patients who may undergo endovascular
procedures.3-5
We studied the perioperative morbidity and mortality
associated with these adjunctive retroperitoneal proce-
dures, as compared with conventional bilateral femoral
exposure, during endovascular AAA repair.
METHODS
Between August 1997 and July 2000, 19 patients un-
derwent endovascular AAA repair during the early phase of
the aortic endovascular program. From August 2000 to
November 2002, a systematic protocol for routine screen-
ing of all patients with intact infrarenal AAA who met
clinical indications for repair was implemented to deter-
mine anatomic eligibility for endovascular treatment. Dur-
ing these latter 28 months 241 patients with infrarenal AAA
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underwent either open surgical (n  95, 39%) or endovas-
cular repair (n  146, 61%). Of the 95 patients who
underwent open surgical repair, 24 were anatomic candi-
dates but did not undergo endovascular repair, because of
patient preference (19 patients), surgeon preference (1
patient), device unavailability (2 patients), or misinterpre-
tation of preoperative computed tomography (CT) scans (2
patients). All patients were evaluated and underwent treat-
ment at a single, tertiary care university medical center by a
group of six board-certified vascular surgeons. The primary
preoperative imaging method was spiral CT angiography,
with three-dimensional reconstructions, including surface
shaded renderings and multiplanar reconstructed images.
Conventional preoperative angiography was performed in
fewer than 10% of patients. All procedures were performed
with the patient under general endotracheal anesthesia in
the operating room, with a portable fluoroscopy unit (GE-
OEC, Salt Lake City, Utah).
Over the entire study period 165 patients (August
1997–July 2000, n  19; August 2000–November 2002,
n  146) underwent endovascular AAA repair. AneuRx
stent grafts were used in 142 patients, Ancure in 11 pa-
tients, and Vanguard (Meditech/Boston Scientific, Natick,
Mass) in 12 patients. In 1 patient undergoing attempted
repair with an AneuRx device, intraoperative conversion to
open surgery was required after misdeployment of the
primary bifurcated device almost entirely into an aneurys-
mal ipsilateral common iliac artery, precluding any chance
for cannulation of the contralateral limb opening. This
patient was excluded from the current study, leaving a final
cohort of 164 patients, with a technically successful proce-
dure completion rate of 99.4%.
In 32 of 164 patients (20%) one or more adjunctive
retroperitoneal iliac procedures were required to facilitate
endovascular AAA repair, whereas in 132 patients repair
was performed successfully via femoral exposure. Indica-
tions for retroperitoneal procedures included internal iliac
(hypogastric) artery revascularization (16 of 32 patients,
50%) and small external iliac arteries (16 of 32 patients,
50%). Choice of arterial access was made on the basis of the
largest diameter of the external iliac artery as measured at
preoperative CT angiography, along with qualitative assess-
ment of the tortuosity and calcification. The only absolute
indications for primary retroperitoneal iliac access were
bilateral small (8 mm) external iliac arteries or borderline
arteries with significant combination of calcification and
tortuosity. If, however, one external iliac artery was small
and the other of adequate size, attempts were made to pass
the larger of the two sheaths through the larger artery and
the smaller sheath through the smaller artery. Intraopera-
tive angiography, direct assessment of the femoral artery
after surgical exposure, failure of serial dilation, and balloon
angioplasty all were secondary considerations in the deci-
sion to obtain retroperitoneal access. Previous groin proce-
dures (eg, vascular bypass, hernia repair) were not indica-
tions in and of themselves for a retroperitoneal approach.
Femoral exposure Femoral exposure consisted of a 5
cm transverse oblique incision made 1 cm inferior to the
inguinal ligament. The femoral artery was catheterized via
assisted percutaneous arterial puncture performed under
direct vision. All retractors were removed, and the incision
was allowed to collapse for the duration of the procedure
except during exchange of introducer sheaths. Purely per-
cutaneous entry, even for the smaller contralateral sheaths
(12F), was not used. All femoral arteries were repaired
primarily, with endarterectomy and prosthetic patch angio-
plasty, or with a short prosthetic interposition graft, and the
incisions were closed routinely in multiple layers.
Retroperitoneal exposure. Pelvic retroperitoneal iliac
exposure involved a 10 to 15 cm curvilinear incision cen-
tered at approximately half the distance between the umbi-
licus and the anterior superior iliac spine. The anterior
rectus sheath was sharply incised along its lateral border,
and the ipsilateral rectus muscle was retracted medially to
gain access to the retroperitoneal space. This is an entirely
muscle-sparing approach to the pelvic retroperitoneum,
which is simply closed with reapproximation of the anterior
rectus sheath. The approach reliably exposed the iliac bifur-
cation, from which an iliac conduit based off the distal
common iliac artery, hypogastric artery bypass or transpo-
sition, and iliofemoral bypass may all be readily performed.
These procedures have been previously described.3,4 In
brief, in small or diseased external iliac arteries, an iliac
conduit is constructed of a 10 mm Dacron graft anasto-
mosed end-to-side to the iliac bifurcation. The other end is
tunneled through the inguinal ligament to the groin
through a small stab incision made directly over the com-
mon femoral artery. This enables a smoother angle of entry
for the sheaths into the iliac artery. After distention under
arterial pressure, all catheter and guide wire manipulations
are performed through this conduit, completely bypassing
the diseased external iliac artery. This conduit may be
amputated at its base and oversewn after completion of the
endovascular procedure; alternatively, if the external iliac or
femoral pulse is diminished, the conduit may be retunneled
anatomically below the inguinal ligament and anastomosed
to the femoral artery as an iliofemoral bypass graft.
All patient data were prospectively gathered in a dedi-
cated aortic endovascular database, which included stan-
dard demographic information, cardiovascular risk factors,
and pertinent preoperative anatomic, intraoperative proce-
dural, and postoperative follow-up data. Preoperative car-
diovascular risk factors included previous history of hyper-
tension, coronary artery disease (angina, coronary artery
bypass grafting, percutaneous coronary angioplasty), pe-
ripheral occlusive disease (claudication, ankle-brachial in-
dex 0.9, leg revascularization), chronic obstructive pul-
monary disease, diabetes mellitus, chronic renal
insufficiency (serum creatinine concentration 1.3 mg/
dL), congestive heart failure (New York Heart Association
class II or greater6), cerebrovascular occlusive disease (tran-
sient ischemic attack, stroke, carotid endarterectomy), and
arrhythmia (atrial fibrillation, stable ventricular or atrial
ectopy). Preoperative risk stratification was based on the
American Society of Anesthesiologists (ASA) Physical Sta-
tus Classification system.7 (Note: The original classification
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has been revised many times, most recently in 1961.) High
risk was defined as ASA class IV (severe systemic disease that
is an ongoing threat to life) or higher. External iliac arteries
were considered small if they were less than 8 mm in
diameter. Common and hypogastric arteries with focal
diameter 20 mm or greater were considered aneurysmal.
Postoperative data included detailed records of all compli-
cations and device-related secondary procedures. All pa-
tients, regardless of whether they underwent retroperitone-
al-assisted or femoral-only endograft procedures, were
admitted to the general care ward, without intensive care
unit observation.
Perioperative outcome for the 32 patients who re-
quired retroperitoneal procedures were compared with that
for the 132 patients in whom endovascular AAA repair was
performed through femoral exposure alone. The primary
end points of the study were perioperative death and com-
plications, and total hospital length of stay. Perioperative
was defined as all intraoperative, postoperative in-hospital,
and outpatient 30-day procedure-related events. All cate-
gorical data were analyzed with the Fisher exact test, and
continuous data were analyzed with the Student t test and
the Wilcoxon rank-sum test. P  .05 (two-tailed) was
considered significant. All values, unless otherwise speci-
fied, are given as mean  SD.
RESULTS
Patient demographic data. Age, body mass index,
and mean number of cardiovascular risk factors per patient
were similar between the femoral group (femoral access
only, n  132) and the retro group (adjunctive retroperi-
toneal procedure, n  32; Table I). However, there was a
significantly greater proportion of women, incidence of
peripheral vascular occlusive disease, and patients at high
risk in the retro group compared with the femoral group.
While proximal neck dimension was similar between the
two groups, maximum AAA diameter was almost 5 mm
larger in the femoral group than in the retro group (Table
II). Forty-eight (29%) of the overall group of 164
patients had one or more concomitant iliac aneurysms,
with a significantly greater proportion of patients with
iliac aneurysm in the retro group than in the femoral group.
In addition, patients in the retro group more commonly
had two or more iliac aneurysms (retro group, 11 of 15
patients, 73%; femoral group, 7 of 33 patients, 21%; P 
.001).
Procedural data. The distribution of devices in the
femoral and retro groups is shown in Table III. In the
femoral group, 16 patients (12%) had either unilateral (n
9) or bilateral (n  7) small external iliac arteries at preop-
erative imaging. In the 9 patients with unilateral small
external iliac arteries, the contralateral external iliac artery
was large enough to pass the larger introducer sheath
(22F), and the side with the small external iliac artery
allowed passage of the smaller introducer sheath (16F-
12F), thereby enabling complete transfemoral access. For
the 7 patients who had bilateral small external iliac arteries,
however, the decision to attempt transfemoral passage of
the introducer sheaths was made intraoperatively on the
basis of qualitative assessment of the common femoral
arteries. Sixteen of 132 patients (12%) in the femoral group
required either common femoral endarterectomy with
prosthetic patch angioplasty (14 patients) or common fem-
Table I. Patient demographic data
Retro
group
(n  32)
Femoral
group
(n  132) P
Age (y) 71.5  7.6 73.2  9.0 .326
Sex (M:F) 22:10 126:6 .0001
BMI (kg/m2) 26.6  3.7 27.5  4.7 .312
CV risk factors
(no. per patient)
2.8  1.4 2.6  1.4 .365
PVOD 11 (34) 17 (13) .007
High risk 10 (31) 17 (13) .018
Coumadin 3 (9) 15 (11) 1.000
Values represent mean  SD, unless otherwise noted.
Retro group, Adjunctive retroperitoneal procedure; femoral group, femoral
access only; BMI, body mass index; CV, cardiovascular; PVOD, peripheral
vascular occlusive disease.
Table II. Preoperative anatomic data
Retro group
(n  32)
Femoral
group
(n  132) P
Proximal neck diameter
(mm)
22.3  2.4 22.9  2.1 .157
Proximal neck length
(mm)
27.0  14.1 27.7  14.1 .802
AAA diameter (mm) 54.0  10.5 58.7  12.3 .048
Iliac aneurysm 15 (47) 33 (25) .018
One 4 (12) 26 (20) .449
Two 9 (28) 5 (4) .0001
Three 1 (3) 2 (1) .481
Four 1 (3) 0 (0) .196
Small EIA (N) 10 (31) 16 (12) .014
Numbers in parentheses are percent.
Retro group, Adjunctive retroperitoneal procedure; femoral group, femoral
access only; AAA, atropic aortic aneurysm; EIA, external iliac artery.
Table III. Distribution of endograft devices
Retro
group
(n  32)
Femoral
group
(n  132)
Total
(n  164)
Vanguard 0 12 12
Ancure 2* 9 11
AneuRx 30 111 141
Retro group, Adjunctive retroperitoneal procedure; femoral group, femoral
access only.
*One patient underwent hypogastric revascularization, and one patient
required iliac conduit because of bilateral, severely diseased external iliac
arteries.
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oral artery replacement with a short interposition graft (2
patients), because of significant arterial injury during pas-
sage of the larger introducer sheaths. Of these 16 patients,
3 had small external iliac arteries at preoperative evaluation.
In the retro group, 38 separate retroperitoneal proce-
dures were performed in 32 patients, including construc-
tion of 8 iliac conduits (only), and creation of 14 iliofemo-
ral bypass grafts and 16 hypogastric artery bypass grafts or
transpositions. Four patients (13%) underwent bilateral
retroperitoneal procedures. Two patients required pros-
thetic patch angioplasty to repair the common femoral
arteries contralateral to the retroperitoneal iliac procedures,
and 2 other patients underwent emergent retroperitoneal
procedures to repair iliac artery rupture caused during
passage of the introducer sheaths.
Perioperative morbidity and mortality. Early post-
operative mortality was similar between the two groups
(retro group, 1 of 32 patients, 3%; femoral group, 2 of 132
patients, 2%; P .48). In the retro group, 1 patient died on
postoperative day 26 of a myocardial infarction and sepsis
from ischemic colitis after inadvertent bilateral hypogastric
artery occlusion, on one side during anastomosis of the iliac
conduit directly over a diseased hypogastric artery orifice,
and on the other side from passage of the introducer sheath
in a severely calcified external iliac artery. In the femoral
group, 1 patient died on postoperative day 2, of colonic
infarction after carbon dioxide angiography and likely gas
embolization, and another patient died of unspecified car-
diac event on postoperative day 12.
Both blood loss and procedure duration were nearly
twice that in the retro group compared with the femoral
group (Table IV). Median hospital length of stay in the
retro group was 1.5 days longer than in the femoral group
(3.5 days [range, 2-61 days] vs 2.0 days [range, 1-15 days;
P  .0001). Two patients in the retro group were dis-
charged on postoperative days 58 and 61, respectively.
Each had significant chronic obstructive pulmonary disease
preoperatively, and the hospital course was complicated
with respiratory failure requiring tracheostomy. Both pa-
tients were alive and well at 17 and 16.5 months, respec-
tively.
Incidence of perioperative complications was almost
twice as high in the retro group compared with the femoral
group (19 of 32 patients, 59%, vs 43 of 132 patients, 33%;
P .008) (Table V). In particular, incidence of respiratory
failure (6% vs 0%, P  .04), ileus (delayed bowel function
beyond 3 days, 6% vs 0%, P  .04), and thrombotic
complications (6% vs 0%, P  .04) was significantly higher
in the retro group than in the femoral group. Both throm-
boses were in the retro group, and involved one early
thrombosis of a hypogastric bypass graft and one femoral
thrombosis from an unrecognized dissection. At mean
follow-up of 12 months (range, 1-26 months), 94% (15 of
16) of hypogastric revascularizations remained patent, as
documented with follow-up CT scans and all 15 patients
free of symptoms of hip or buttock claudication. Twelve
inadvertent hypogastric occlusions occurred (Table V),
from endograft misdeployment as a result of either mis-
identification of the hypogastric artery origin or incorrect
selection of device length (n 11) or iliac artery dissection
at the hypogastric artery orifice (n  1).
DISCUSSION
We compared early clinical outcome of endovascular
AAA repair performed with adjunctive retroperitoneal pro-
cedures versus those done via femoral exposure only. The
primary end points of the study were incidence of periop-
erative morbidity and mortality, and hospital length of stay.
Our results indicated that, although adjunctive retroperito-
neal procedures were associated with increased median
length of stay and higher incidence of perioperative com-
plications, early postoperative mortality was not increased.
This was achieved despite the proportion of patients at high
risk in the retro group being over twice that in the femoral
group. This higher incidence of patients at high risk in the
retro group likely represents referral bias, in which patients
who pose both an unfavorable surgical risk and unfavorable
anatomy for endovascular repair are preferentially referred
to an endovascular tertiary care center.
Table IV. Intraoperative procedural data
Retro
group
(n  32)
Femoral
group
(n  132) P
Fluoroscopy (min) 31  12 29  13 .345
Contrast load (mL) 86  35 95  30 .154
Estimated blood loss (mL) 648  650 247  275 .0001
Procedure (min) 324  83 178  63 .0001
Retro group, Adjunctive retroperitoneal procedure; femoral group, femoral
access only.
Table V. Rate of perioperative complications
Retro
group
(n  32)
Femoral
group
(n  132)
Pn % n %
Arterial injury 6 (19) 19 (14) .585
Internal iliac occlusion 3 (9) 9 (7) .704
MI/CHF/arrhythmia 3 (9) 3 (2) .089
Respiratory failure 2 (6) 0 (0) .037
Renal insufficiency* 2 (6) 3 (2) .251
Claudication 5 (16) 9 (7) .151
Ileus 2 (6) 0 (0) .037
Ischemic colitis 2 (6) 1 (1) .098
Wound complication 2 (6) 14 (11) .740
Bleeding 2 (6) 1 (1) .098
Arterial thrombosis 2 (6) 0 (0) .037
Other† 1 (3) 4 (3) 1.000
Retro group, Adjunctive retroperitoneal procedure; femoral group, femoral
access only; MI, myocardial infarction; CHF, congestive heart failure.
*Postoperative increase in serum creatinine concentration 0.3 mg/dL
above preoperative level.
†Includes thromboembolism and device malfunction.
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The indications for adjunctive retroperitoneal proce-
dures were need for hypogastric revascularization and iliac
conduits because of small external iliac arteries. For com-
mon iliac aneurysms that are too large to allow a “bellbot-
tom” technique with an aortic cuff,8 distal iliac fixation
must be in the external iliac arteries. However, acute uni-
lateral occlusion of patent hypogastric arteries (simple
stent-graft coverage or coil embolization) may result in up
to 40% risk for clinically significant hip and buttock claudi-
cation, as well as other complications of pelvic ischemia.9
Indeed, the 1 death in the retro group was due to severe
colorectal ischemia after acute bilateral hypogastric occlu-
sion. In the setting of common iliac aneurysm with planned
extension to the external iliac artery, we have advocated
elective hypogastric revascularization (vs embolization),
with either hypogastric transposition to the external iliac
artery or direct external iliac artery to hypogastric artery
bypass grafting4,10 in patients with bilateral common iliac
aneurysm with involvement of both hypogastric arteries or
who are sufficiently ambulatory and do not wish to risk the
40% chance of hip or buttock claudication.
Patients preoperatively identified as having small exter-
nal iliac arteries routinely underwent intraoperative diag-
nostic angiography during the endograft procedure before
passage of the introducer sheaths. We have found that CT
scans are more reliable for sizing the iliac arteries and
predicting success (or failure) of a transfemoral approach
than conventional angiograms, where even in the presence
of angiographically significant occlusive disease the sheaths
could be passed easily, and conversely, deceptively normal
appearing iliac arteries posed significant resistance. Because
of the substantial risks associated with iliac artery disruption
or rupture, we have readily resorted to an iliac conduit.
Most patients in the retroperitoneal group with iliac
conduits required only unilateral procedures, because the
delivery catheters in the contralateral limbs of all three
commercially available devices are significantly smaller than
their corresponding primary bifurcated devices. The An-
cure device requires a 24F (minimum vessel diameter 8
mm) primary introducer sheath and a 12F contralateral
sheath, and the AneuRx device requires a 22F (minimum
vessel diameter 7.5 mm) and a 16F contralateral sheath.
Therefore, with small diseased arteries, whereas the con-
tralateral device can usually be passed from the femoral
artery in most situations, the primary device almost always
requires retroperitoneal access. Of the 16 patients in the
retro group who required an iliac conduit, only 1 received
the Ancure device. Device type was not important in this
patient who required iliac access; the patient had bilateral,
severely diseased small external iliac arteries that would not
have allowed passage of even the 22F sheath required of the
AneuRx system. Serial dilation with special hydrophilic
dilators (Endovascular Dilator Set; Cook, Bloomington,
Ind) and balloon angioplasty was not successful in these
patients. The Excluder system (Gore), which has been
recently approved by the US Food and Drug Administra-
tion for commercial use, may offer a significant advantage
in such situations. This device has the lowest profile of the
three aortic endograft systems, with the primary bifurcated
device requiring only an 18F (minimum vessel diameter
6.1 mm) introducer sheath and a 12F contralateral
sheath.
Adjunctive retroperitoneal procedures during endovas-
cular AAA repair have become part of the standard tech-
niques used by most experienced endovascular aortic oper-
ators, and have served to significantly expand the subset of
patients who may undergo endovascular techniques. Esti-
mates of anatomic eligibility of unselected cohorts of pa-
tients with infrarenal AAA vary between 30% and 60%
among published series.1,2 These estimates, however, com-
prise a heterogeneous mixture of criteria for anatomic
eligibility, span both the early and late phases of an institu-
tion’s learning curve, and involve a variety of custom tech-
niques to facilitate endovascular repair. Therefore it is prob-
ably safe to say that true estimates of anatomic eligibility
based on strict guidelines are not known. With recognition
of these limitations, however, during the 28 months when
all patients with intact infrarenal AAA clinically indicated
for repair were screened for endovascular treatment, 71%
(170 of 241 patients [146 endovascular repair, 24 open
surgical repair]) of patients who were anatomically eligible
for endovascular techniques were able to undergo endovas-
cular and adjunctive surgical techniques. If these ancillary
methods were not available, at least 32 patients would not
have been candidates for endovascular repair, which would
have reduced the anatomic endovascular eligibility rate to
57%.
CONCLUSIONS
Adjunctive retroperitoneal surgical procedures can sig-
nificantly expand the number of patients who can undergo
endovascular repair. These same patients, however, sustain
significantly more complications and require longer hospi-
talization after these procedures. Despite these outcome
measures, adjunctive retroperitoneal procedures during en-
dovascular AAA repair may still be performed safely with-
out additional mortality in patients at high risk for whom
options for AAA repair are limited.
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DISCUSSION
Dr William Jordan (Birmingham, Ala). Thank you, Dr Hu-
ber, Dr Hansen. First I want to congratulate Dr Lee on his
eloquent presentation of the continued scholarly pursuits at the
University of Florida. In this series he and his colleagues presented
a 5-year experience with endovascular repair of 171 aneurysms.
Most of the experience is in the last 22 years, which reflects a wave
of endo-enthusiasm that has swept across our southern region and
our country. The authors identified the ability to expand this
minimally invasive approach to an additional 14% of their patients.
Specifically, this is most often related to the difficulty with the
access through the iliofemoral segment to place these large-diam-
eter endografts into the aneurysm proper. Dr Lee has demon-
strated to us that the retroperitoneal approach can offer an ap-
proach for iliac conduit or for iliofemoral bypass or for direct
hypogastric revascularization. While their operative time, blood
loss, and total complication rate were increased, the overall mor-
tality was similar. Anthony, your determination should be ap-
plauded, as you have expanded the application of this technique to
more patients, yet you still remain under Dr Sternbergh’s endo-
enthusiasm limit of 60%.
Now, to address the concept of iliac access, I would like to
borrow from the motif of the recent film of Tolkein’s Lord of the
Rings. You remind me of Balrog, who stood before Gandalf on the
bridge of Kaza-dum in the Mines of Moria. The wizard exclaimed
to the demon that “Thou shalt not pass,” yet you found a way to
get around these small iliac arteries or to address large common
iliacs. I want to direct three questions to you, please.
First, you used 8 mm as a minimum diameter to avoid femoral
access. Were all the patients that were imaged who had an iliac
artery less than 8 mm then committed to a retroperitoneal ap-
proach? In our experience at UAB we found that many smaller
iliacs could be gently dilated with dilators or with balloon angio-
plasty. Furthermore, how many of the 40% of patients with open
repairs were denied endovascular repair because of iliac access
problems? It seems that the AneuRx device could be passed
through 7 mm vessels, and even smaller vessels, if calcification is
limited. How much did calcification play a role in your decision to
go directly to the retroperitoneal access versus an attempt at
transfemoral approach?
Second, some have suggested the procedure is simple and not
much more involved than the femoral approach. However, these
operations required more time and had more blood loss than the
standard femoral approach, as you have shown us here. Addition-
ally, there were more patients who suffered an ileus after this
retroperitoneal approach, suggesting that there may still be some
intraperitoneal insult to this maximally exposed, minimally invasive
operation. Your increased complication rates approach some re-
ports of open repair. Some then may advocate the more durable
open reconstruction rather than this approach outlined here. Why
not just open the patient up? You used a retroperitoneal incision
for internal iliac revascularization in 16 or 17 cases, which repre-
sents almost 10% of your total endovascular experience. In the
manuscript you also noted a 15% claudication rate in this group. In
our experience in Birmingham, we have often used hypogastric
embolization, and rarely use revascularization, but seem to have a
similar claudication rate after the procedure. Are you convinced
that adding this bypass is necessary for patients, also realizing that
many are in such ill health that they do not undertake such
vigorous activity to even have hip claudication?
Finally, I have some issue about your high-risk classification.
You use the anesthesiologist classification system, which too often
may seem subjective and motivated differently from factors that the
surgeon traditionally uses to assess a patient. Have you categorized
other risk factors, such as degree of coronary artery disease or
ventricular function, and their effect on perioperative morbidity
and mortality?
Again, Anthony, I enjoyed the paper. I am thankful that you
were able to forward it to me well in advance of the meeting, and
I also ask that all in the audience realize that this is an aggressive
approach toward challenging iliac anatomy that we all face, and
that you also have been able to overcome those prohibitions of the
gray-haired Gandalf, who suggested that you shall not pass. So,
Anthony, Sir Balrog, how do you respond? Thank you.
Dr W. Anthony Lee. Will, thank you for that discussion. I
think the current situation is that we have the skills to overcome
some of these unfavorable iliac anatomies and that they, in and of
themselves, should not deny somebody who may strongly wish
an endovascular treatment of their aneurysms, and certainly if
their comorbid status would make endovascular repair a more
attractive option. Specifically, external iliac arteries that are
less than 8 mm are a significant risk factor for intraoperative
complications. Indeed, two patients had inadvertent retroperito-
neal exposures after external iliac artery ruptures. We have tried
all sorts of adjunctive maneuvers, including serial, hydrophilic
dilators and balloon angioplasties, and in a couple of cases we have
actually put in a covered stent preoperatively to superdilate these
arteries. None of these methods were successful in our hands. That
is the main reason for going directly to these retroperitoneal
conduits.
In regard to your question about the remaining 40% who were
not eligible for endovascular repair, the 40% was due to proximal
neck issues that could not be overcome.
Did calcification play a role? Yes, certainly it did. Even in
marginally sized arteries, if they are relatively free of calcifications,
it is possible to pass 22F sheaths.
I would not term these retroperitoneal procedures, whether
they are iliac conduits or hypogastric bypasses, as simple. I think
they are fairly involved, and our data regarding their procedure
time and postoperative morbidity also supports that. Why not,
then, convert these or offer them an open aneurysm repair from the
start? Well, the answers to that reflect what I said earlier about
some people who strongly desire endovascular repair, or their
comorbid status may sometimes sway one toward that route.
Although the data are not presented in this paper, it is our
retroperitoneal experience that, despite the incremental surgical
stress of these procedures, when you see them back in clinic they
are functionally better than people who have undergone open
aneurysm repair.
With regard to the indications for hypogastric artery bypass,
about 3 years ago three papers were published in two separate
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